Analysis on Survival and Prognostic Factors in Patients with Resectable Pancreatic Adenocarcinoma

被引:8
作者
Lin, Rong [1 ]
Han, Chao-qun [1 ]
Wang, Wei-jun [1 ]
Liu, Jun [1 ]
Qian, Wei [1 ]
Ding, Zhen [1 ]
Hou, Xiao-hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; survival; prognosis; lymph node ratio; LONG-TERM SURVIVAL; LYMPH-NODE RATIO; NEOADJUVANT THERAPY; RISK-FACTORS; CANCER; RESECTION; OBESITY; IMPACT; LYMPHADENECTOMY; GEMCITABINE;
D O I
10.1007/s11596-017-1780-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR <= 0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 41 条
[11]   The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy [J].
Fischer, Laurice K. ;
Katz, Matthew H. ;
Lee, Sun M. ;
Liu, Li ;
Wang, Hua ;
Varadhachary, Gauri R. ;
Wolff, Robert A. ;
Lee, Jeffrey E. ;
Maitra, Anirban ;
Roland, Christina L. ;
Fleming, Jason B. ;
Estrella, Jeannelyn ;
Rashid, Asif ;
Wang, Huamin .
HISTOPATHOLOGY, 2016, 68 (02) :210-220
[12]   Extended Lymphadenectomy in Pancreatic Cancer Is Crucial [J].
Fujii, Tsutomu .
WORLD JOURNAL OF SURGERY, 2013, 37 (08) :1778-1781
[13]   Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma [J].
Gaujoux, Sebastien ;
Torres, Javiera ;
Olson, Sara ;
Winston, Corrine ;
Gonen, Mithat ;
Brennan, Murray F. ;
Klimstra, David S. ;
D'Angelica, Michael ;
DeMatteo, Ronald ;
Fong, Yuman ;
House, Michael ;
Jarnagin, William ;
Kurtz, Robert C. ;
Allen, Peter J. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) :2908-2916
[14]   A Prospective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection, Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head Cancer [J].
Jang, Jin-Young ;
Kang, Mee Joo ;
Heo, Jin Seok ;
Choi, Seong Ho ;
Choi, Dong Wook ;
Park, Sang Jae ;
Han, Sung-Sik ;
Yoon, Dong Sup ;
Yu, Hee Chul ;
Kang, Koo Jeong ;
Kim, Sang Geol ;
Kim, Sun-Whe .
ANNALS OF SURGERY, 2014, 259 (04) :656-664
[15]   Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation [J].
Krishnan, Sunil ;
Rana, Vishal ;
Janjan, Nora A. ;
Abbruzzese, James L. ;
Gould, Morris S. ;
Das, Prajnan ;
Delclos, Marc E. ;
Palla, Shana ;
Guha, Sushovan ;
Varadhachary, Gauri ;
Evans, Douglas B. ;
Wolff, Robert A. ;
Crane, Christopher H. .
CANCER, 2006, 107 (11) :2589-2596
[16]   Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery [J].
Lagergren, Jesper ;
Mattsson, Fredrik ;
Zylstra, Janine ;
Chang, Fuju ;
Gossage, James ;
Mason, Robert ;
Lagergren, Pernilla ;
Davies, Andrew .
JAMA SURGERY, 2016, 151 (01) :32-39
[17]   Prognostic Factors Associated with Long-Term Survival and Recurrence in Pancreatic Adenocarcinoma [J].
Lee, Sung Ryol ;
Kim, Hyung Ook ;
Son, Byung Ho ;
Yoo, Chang Hak ;
Shin, Jun Ho .
HEPATO-GASTROENTEROLOGY, 2013, 60 (122) :358-362
[18]   Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis [J].
Li, Doudou ;
Chen, Changhao ;
Zhou, Yu ;
Chen, Rufu ;
Fan, Xinxiang ;
Bi, Zhuofei ;
Li, Zhihua ;
Liu, Yimin .
MEDICINE, 2015, 94 (35) :e1345
[19]   Lymph node evaluation for treatment of adenocarcinoma of the pancreas [J].
Marmor, Schelomo ;
Burke, Erin E. ;
Portschy, Pamela R. ;
Virnig, Beth A. ;
Jensen, Eric H. ;
Tuttle, Todd M. .
SURGICAL ONCOLOGY-OXFORD, 2015, 24 (03) :284-291
[20]   Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer [J].
Miura, John T. ;
Krepline, Ashley N. ;
George, Ben ;
Ritch, Paul S. ;
Erickson, Beth A. ;
Johnston, Fabian M. ;
Oshima, Kiyoko ;
Christians, Kathleen K. ;
Evans, Douglas B. ;
Tsai, Susan .
SURGERY, 2015, 158 (06) :1546-1556